AMYDIS, INC.

Profile

Company Names

AMYDIS, INC.

Addresses

1901 AVENUE OF THE STARS, SUITE 200, LOS ANGELES, CA 90067

1800 CENTURY PARK EAST, SUITE 600, LOS ANGELES, CA 90067

Phone Numbers

310-229-5710

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$14,685,723.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-12-14 
$3,000,000.00 
$6,000,000.00 
$3,000,000.00 
Debt 
2
2022-12-20 
$5,999,991.00 
$9,000,000.00 
$3,000,009.00 
Equity 
1
2022-02-16 
$5,685,732.00 
$5,685,732.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTINE 
 
AYLWARD 
DIRECTOR
CONSEJOSANO, INC.   |  RELATION THERAPEUTICS INC.   |  AMYDIS, INC.   |  MAGNETIC VENTURES FUND II LP   |  WEAVE PLATFORM, INC.
FAITH 
 
CHARLES 
DIRECTOR
AGILVAX, INC.   |  SANDSTONE DIAGNOSTICS INC   |  ENTERA BIO LTD.   |  AMYDIS, INC.   |  AVENUE THERAPEUTICS, INC.   |  CNS PHARMACEUTICALS, INC.
JAMES 
 
KHODABAKHSH 
DIRECTOR
AMYDIS, INC.
STELLA 
 
SARRAF 
EXECUTIVE OFFICER, DIRECTOR
SPINOGENIX, INC.   |  AMYDIS, INC.
JERRE 
L. 
STEAD 
DIRECTOR
PROXIMETRY INC   |  AMYDIS, INC.
JACK 
 
THRIFT, CPA 
EXECUTIVE OFFICER
AMYDIS, INC.
MERVYN 
 
TURNER 
DIRECTOR
PHARMAKEA, INC.   |  ENGENEIC LTD   |  AMYDIS, INC.   |  SPINOGENIX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-12-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-14 
2022-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-20 
2022-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#